Investigation of the Prognostic Significance of Vasculogenic Mimicry and Its Inhibition by Sorafenib in Canine Mammary Gland Tumors

Characterization of OCT3/4, Nestin, NANOG, CD44 and CD24 as stem cell markers in canine prostate cancer

(2019) Camila Dorotea Costa et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

HypoxamiRs Profiling Identify miR-745 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells

(2019) Yarely M. Salinas-Vera et al.   Frontiers in Oncology

Vasculogenic mimicry-associated ultrastructural findings in human and canine inflammatory breast cancer cell lines

(2019) Lucía Barreno et al.   BMC CANCER

Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenib

(2019) Teresa Faranda et al.   Scientific Reports

Ultrasound-Triggered Nanodroplets for Targeted Co-Delivery of Sorafenib/Doxorubicin for Hepatocellular Carcinoma Therapy

(2019) Tan Yang et al.   Journal of Biomedical Nanotechnology

A Multifunctional Lipid-Based Nanodevice for the Highly Specific Codelivery of Sorafenib and Midkine siRNA to Hepatic Cancer Cells

(2019) Mahmoud A. Younis et al.   MOLECULAR PHARMACEUTICS

Sorafenib improves alkylating therapy by blocking induced inflammation, invasion and angiogenesis in breast cancer cells

(2018) Alfeu Zanotto-Filho et al.   CANCER LETTERS

In vitro and in vivo apatinib inhibits vasculogenic mimicry in melanoma MUM-2B cells

(2018) Zong-Jun-Lin Liu et al.   PLoS One

Overview of advances in vasculogenic mimicry – a potential target for tumor therapy

(2018) Hong Ge et al.   Cancer Management and Research

An in-depth review of chemical angiogenesis inhibitors for treating hepatocellular carcinoma

(2017) Jean-Luc Raoul et al.   EXPERT OPINION ON PHARMACOTHERAPY

Sorafenib for the treatment of breast cancer

(2017) Giuseppe Bronte et al.   EXPERT OPINION ON PHARMACOTHERAPY

The relationship between vasculogenic mimicry and epithelial-mesenchymal transitions

(2016) Qiqi Liu et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Targeting Angiogenesis in Cancer Treatments: Where do we Stand?

(2016) Nenad Petrovic   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Canine mammary carcinomas: influence of histological grade, vascular invasion, proliferation, microvessel density and VEGFR2 expression on lymph node status and survival time

(2016) M. E. Diessler et al.   Veterinary and Comparative Oncology

Impact of adding the multikinase inhibitor sorafenib to endocrine therapy in metastatic estrogen receptor-positive breast cancer

(2014) Suleiman Massarweh et al.   Future Oncology

VEGFR-2 expression in malignant tumours of the canine mammary gland: a prospective survival study

(2014) A. Santos et al.   Veterinary and Comparative Oncology

Sorafenib or Placebo with Either Gemcitabine or Capecitabine in Patients with HER-2-Negative Advanced Breast Cancer That Progressed during or after Bevacizumab

(2013) L. S. Schwartzberg et al.   CLINICAL CANCER RESEARCH

Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Plays a Key Role in Vasculogenic Mimicry Formation, Neovascularization and Tumor Initiation by Glioma Stem-like Cells

(2013) Xiaohong Yao et al.   PLoS One

Abstract 4651: Sorafenib and its derivatives induce apoptosis and autophagy in canine mammary tumor cells

(2012) Yi-Yen Lee et al.   CANCER RESEARCH

A double-blind, randomised, placebo-controlled, phase 2b study evaluating sorafenib in combination with paclitaxel as a first-line therapy in patients with HER2-negative advanced breast cancer

(2012) William J. Gradishar et al.   EUROPEAN JOURNAL OF CANCER

Sorafenib in Combination With Capecitabine: An Oral Regimen for Patients With HER2-Negative Locally Advanced or Metastatic Breast Cancer

(2012) José Baselga et al.   JOURNAL OF CLINICAL ONCOLOGY

Classification and Grading of Canine Mammary Tumors

(2011) M. Goldschmidt et al.   VETERINARY PATHOLOGY

Vascular endothelial growth factor receptor-2 in breast cancer

(2010) Shanchun Guo et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer

(2010) Claudine Isaacs et al.   BREAST CANCER RESEARCH AND TREATMENT

Histological, Immunohistological, and Ultrastructural Description of Vasculogenic Mimicry in Canine Mammary Cancer

(2010) M. Clemente et al.   VETERINARY PATHOLOGY